Evidence map›Paper›PMID 35456974›Full record

ArticleInternational journal of molecular sciences2022

SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets.

Angelo Boccia, Rossella Tufano, Veronica Ferrucci, Leandra Sepe, Martina Bianchi, Stefano Pascarella, Massimo Zollo, Giovanni Paolella

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Angelo BocciaCeinge Biotecnologie Avanzate, 80145 Naples, Italy.
Rossella TufanoCeinge Biotecnologie Avanzate, 80145 Naples, Italy.
Veronica FerrucciCeinge Biotecnologie Avanzate, 80145 Naples, Italy.ORCID 0000-0002-2019-6501
Leandra SepeCeinge Biotecnologie Avanzate, 80145 Naples, Italy.ORCID 0000-0001-6669-2503
Martina BianchiDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza Università di Roma, 00185 Rome, Italy.
Stefano PascarellaDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza Università di Roma, 00185 Rome, Italy.ORCID 0000-0002-6822-4022
Massimo ZolloCeinge Biotecnologie Avanzate, 80145 Naples, Italy.ORCID 0000-0002-0970-7243
Giovanni PaolellaCeinge Biotecnologie Avanzate, 80145 Naples, Italy.
Ceinge Biotecnologie Avanzate (Italy) · ITSapienza University of Rome · IT

Funding

Ministry of Education, Universities and Research PON01_00486 Programma Operativo Nazionale "Ricerca e Competitività 2007-2013"Regione Campania "CEINGE TASK-FORCE COVID19," code D64I200003800
6 · The paper itself

Abstract

Tracing the appearance and evolution of virus variants is essential in the management of the COVID-19 pandemic. Here, we focus on SARS-CoV-2 spread in Italian patients by using viral sequences deposited in public databases and a tracing procedure which is used to monitor the evolution of the pandemic and detect the spreading, within the infected population of emergent sub-clades with a potential positive selection. Analyses of a collection of monthly samples focused on Italy highlighted the appearance and evolution of all the main viral sub-trees emerging at the end of the first year of the pandemic. It also identified additional expanding subpopulations which spread during the second year (i.e., 2021). Three-dimensional (3D) modelling of the main amino acid changes in mutated viral proteins, including ORF1ab (nsp3, nsp4, 2'-o-ribose methyltransferase, nsp6, helicase, nsp12 [RdRp]), N, ORF3a, ORF8, and spike proteins, shows the potential of the analysed structural variations to result in epistatic modulation and positive/negative selection pressure. These analyzes will be of importance to the early identification of emerging clades, which can develop into new "variants of concern" (i.e., VOC). These analyses and settings will also help SARS-CoV-2 coronet genomic centers in other countries to trace emerging worldwide variants.

Indexed as

COVID-19SARS-CoV-2HumansMutationPandemicsSpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2SARS-CoV-2variant of concern (VOC)viral variants tracing

Identifiers

PMID35456974
PMCPMC9029933
OpenAlexW4224274638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.